Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.
Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.
Shlaes
D M
DM
Wyeth-Ayerst Research, Pearl River, New York 10965, USA.
Gerding
D N
DN
John
J F
JF
Craig
W A
WA
Bornstein
D L
DL
Duncan
R A
RA
Eckman
M R
MR
Farrer
W E
WE
Greene
W H
WH
Lorian
V
V
Levy
S
S
McGowan
J E
JE
Paul
S M
SM
Ruskin
J
J
Tenover
F C
FC
Watanakunakorn
C
C
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D003428:Cross Infection / Q000382:microbiology / Q000517:prevention & control; D004352:Drug Resistance, Microbial / Q000235:genetics; D006760:Hospitalization; D006761:Hospitals; D006801:Humans; D010356:Patient Isolation; D012955:Societies, Medical; D014481:United States; D014774:Virulence
D000900:Anti-Bacterial Agents